18000 doses a day in anz, page-85

PoS, I guess my point is why get caught up in a 4% marketshare figure, when it is obvious, to me at least, that either this works or it doesn't. If it does, then in the absence of any other comparitive option and the advantage of doing away with unhealthy drugs, th worth of this just in the Australian and NZ market to POH has to be more than its current marketcap of $90mill (taking into account the application of a PE on profits).

Then we have those trying to devalue the importance of MMA, some even making absurd claims that this is some sort of gimmick organisation thought up by POH themselves.

MMA will be a critical partner in the marketing of this product. This announcement creates serious value. The only thing missing now is the revenue, and this they have earmarked to begin in the 2nd half of 2011. In other words, its going to be commercialised.

K now after rereading that I agree with you Pos, people just don't understand TPM.